$TPB

Why Turning Point Brands Stock Dived by 10% Today

Turning Point Brands (TPB) stock fell 10% on Monday due to unexpected CEO departure and a cut in EBITDA guidance. CEO Graham Purdy is leaving for personal reasons, and David Glazek will take over. The company reduced its full-year EBITDA forecast to $70M from $80M but maintained sales estimates for its oral tobacco products.

Original reporting
Published Sep 21, 2026, 11:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 21, 2026, 11:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Why Turning Point Brands Stock Dived by 10% Today — source image
Decision brief

The 30-second read

$TPBBearishHigh
01

Why it matters

The dual shock of a sudden CEO departure and a downward revision of EBITDA guidance triggered a 10% intraday decline, indicating heightened risk perception.

02

Market read

The news directly affects TPB's share price and may influence sentiment toward the broader oral tobacco niche.

03

What to watch

Potential upside from upcoming FDA decisions on competing nicotine products could mitigate the impact.

Relevance 7/10Novelty 7/10Timing: Monday market reaction

Background

Turning Point Brands (TPB) is a niche tobacco company known for chewing tobacco and rolling papers.

Company-level read

Ticker impact

$TPBBearishHigh confidence
Context

Turning Point Brands announced a CEO resignation and cut the high end of its FY EBITDA guidance, causing the stock to fall 10% on Monday.

Expected impact

Short bias expected as the stock may continue to test lower support levels.

Evidence & confidence

Both the leadership turnover and the reduced EBITDA outlook are material, first‑report events that moved the share price sharply.

Market effects

Tobacco and oral nicotine segment may see heightened scrutiny as peers face regulatory and competitive pressures.

U.S. small‑cap consumer discretionary space could see broader sell‑off on similar guidance cuts.

Limited to U.S. investors; no immediate global ripple.

Counterpoint

If the new CEO can accelerate cost cuts, the stock may rebound on the back of a lower cost base.

Key entities

  • Turning Point Brands

    Subject of the article; US‑listed ticker TPB.

  • David Glazek

    Appointed as incoming CEO effective Oct. 1.

Related articles

$TPBHigh

Why is Turning Point Brands stock sliding today?

Turning Point Brands (TPB) stock fell 8.8% after announcing CEO change and lowering 2026 adjusted EBITDA guidance to $70M–$80M, down from $70M–$90M, due to delayed manufacturing benefits and high freight costs. The company reaffirmed its Modern Oral gross sales guidance of $330M–$350M. The decline was driven by company-specific factors, as broader markets rose.

$HDBMed

Banks accelerate capital increases with billions of new shares

Vietnamese banks are accelerating charter-capital increases via bonus shares, stock dividends and rights issues. BIDV plans a 498.2m-share bonus issuance (record Aug 18) and a 4.5% cash dividend (Aug 20). Vietcombank and VietinBank also plan 4.5% cash dividends in late August. Other lenders including MBBank, HDBank, TPBank, VIB, Maritime Bank, VietABank and Vietbank outline additional share issuances and a Vietbank rights offer.

$TPBMedAI 8/10

Turning Point Brands Q2 Earnings Call Highlights

Turning Point Brands (NYSE:TPB) reported Q2 segment updates and raised 2026 Modern Oral outlook. Adjusted gross sales guidance for Modern Oral increased to $330M-$350M and net sales to $260M-$270M. It kept full-year adjusted EBITDA at $70M-$90M. The company said it ended Q2 with $268M cash and $26M free cash flow, helped by an $18M tariff refund.

$TPBHigh

Turning Point Brands, Inc. (TPB): Results of Operations and Financial Condition

Turning Point Brands, Inc. (TPB) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Turning Point Brands Announces Second Quarter 2026 Results ● Q2 2026 Modern Oral Gross Revenue increased 149% to $87.0 million and Net Sales increased 128% to $68.4 million. Accounting for 48% of total company net sales, up from 26% in Q2 2025 ● Raising FY 2026 Moder

$TPBMedAI 9/10

Turning Point Brands Inc. (TPB): A Top Sin Stock to Buy On Growing Nicotine Pouch Opportunity

Turning Point Brands (NYSE:TPB) reported first-quarter results on May 7. Revenue rose 17% year over year to $124.3 million, driven by growth in its Modern Oral nicotine pouch segment. Gross profit increased 14.6% to $68.3 million, while adjusted EBITDA fell 6.5% to $25.9 million as margins contracted to 20.8%. The company said it is investing in sales, marketing, and manufacturing and targets double-digit market share by 2030.